Tuesday, 9 May 2017

Sensex continues to trade flat, Nifty holds 9300

For more Free Stock Tips click here >> http://www.ripplesadvisory.com/free-trial.php

Shares of Aurobindo Pharma were under pressure on Tuesday as it lost over 2 percent intraday due to regulatory issues. The US Food and Drug Administration (FDA) made some observations for the company’s Hyderabad unit and issued a Form 483 for the same. Brokerages, however, retained their buy call on the stock amid a few concerns from these observations.

No comments:

Post a Comment